According to the latest data from the Hong Kong Stock Exchange, on December 18, China International Capital Corporation Limited increased its stake in NOVOSENSE (02676) by 67,200 shares at an average price of HK$113.4707 per share, totaling approximately HK$7.6252 million. Following this transaction, the firm's total holdings in NOVOSENSE rose to approximately 3.6703 million shares, representing a 19.24% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.